Literature DB >> 30137444

Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI: A Summary of the Joint Consensus Document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).

Gregory Y H Lip1, Jean-Philippe Collet2, Michael Haude, Kurt Huber.   

Abstract

Entities:  

Year:  2018        PMID: 30137444     DOI: 10.1093/eurheartj/ehy396

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  7 in total

1.  Using non-vitamin K oral anticoagulants in specific patient populations: a study of Korean cases.

Authors:  Il Young Cho
Journal:  Ther Clin Risk Manag       Date:  2019-10-08       Impact factor: 2.423

2.  Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).

Authors:  Yihong Sun; Jun Zhu; Changsheng Ma; Shaowen Liu; Yanzong Yang; Dayi Hu
Journal:  Cardiovasc Ther       Date:  2019-03-21       Impact factor: 3.023

3.  Trial Sequential Analysis Comparing Bleeding and Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation and Acute Coronary Syndrome on Dual versus Triple Therapy.

Authors:  Muhamad B Munir; Khansa Osman; Maryam Saleem; Kinjan Patel; Sudarshan Balla
Journal:  Cureus       Date:  2019-06-11

Review 4.  A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes.

Authors:  Mohammad Alkhalil; Michał Kuzemczak; Alan Bell; Sol Stern; Michelle Welsford; Warren J Cantor; Shaun G Goodman
Journal:  CMAJ       Date:  2022-02-14       Impact factor: 8.262

5.  Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial.

Authors:  Yohei Sotomi; Ken Kozuma; Kosuke Kashiwabara; Yoshiharu Higuchi; Kenji Ando; Yoshihiro Morino; Junya Ako; Kengo Tanabe; Takashi Muramatsu; Gaku Nakazawa; Shungo Hikoso; Yasushi Sakata
Journal:  BMJ Open       Date:  2021-12-14       Impact factor: 2.692

Review 6. 

Authors:  Mohammad Alkhalil; Michał Kuzemczak; Alan Bell; Sol Stern; Michelle Welsford; Warren J Cantor; Shaun G Goodman
Journal:  CMAJ       Date:  2022-05-02       Impact factor: 16.859

7.  Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges.

Authors:  Ashley Chen; Eric Stecker; Bruce A Warden
Journal:  J Am Heart Assoc       Date:  2020-06-15       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.